Norliqva Solution
Product Images NDC 46287-035
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norliqva (NDC 46287-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cmp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Figure 2 – Effects On Primary Endpoint Of Amlodipine Versus Placebo Across Sub-groups (Norliquid 03)
Principal Display Panel (150 mL Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.